Selective serotonin reuptake inhibitors for stroke recovery

Area of Science:

• Neuroscience
• Pharmacology
• Clinical Neurology

Background:

• Stroke is a leading cause of long-term disability.
• Identifying effective treatments for post-stroke recovery is crucial.
• The role of antidepressants in non-depressed stroke survivors is under investigation.

Purpose of the Study:

• To determine if selective serotonin reuptake inhibitors (SSRIs) improve recovery outcomes after stroke.
• To assess the association between SSRI use and functional recovery in stroke patients.

Main Methods:

• Systematic review and meta-analysis of existing studies.
• Inclusion of trials examining SSRIs for post-stroke recovery.
• Assessment of study quality and risk of bias.

Main Results:

• Preliminary findings suggest a potential benefit of SSRIs for stroke recovery.
• Observed improvements in recovery were noted even in patients without diagnosed depression.
• Significant heterogeneity and limitations in the quality of available evidence were identified.

Conclusions:

• SSRIs might be associated with enhanced recovery post-stroke.
• The current evidence base is largely of poor quality.
• High-quality, large-scale randomized controlled trials are required to validate these findings and precisely estimate treatment effects.